Alex Zhavoronkov, Ph.D.
Insilico
Founder & CEO
Prof. Zhavoronkov is the Founder and CEO of Insilico Medicine, a leader in the next-generation AI for drug discovery, biomarker development, and aging research. Prior to Insilico, he worked in senior roles at ATI Technologies, NeuroG Neuroinformatics, the Biogerontology Research Foundation, and YLabs. AI. Since 2012 he has published over 130 peer-reviewed research papers and 2 books. For 6 years in a row, he has organized the annual Aging Research for Drug Discovery and Artificial Intelligence for Healthcare forums.